60 DEGREES PHARMACEUTICALS, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 1025 CONNECTICUT AVENUE NW, WASHINGTON, DC, 20036
Mailing Address 1025 CONNECTICUT AVENUE NW, WASHINGTON, DC, 20036
Phone 202-327-5422
Fiscal Year End 1231
EIN 452406880
Financial Overview
FY2024
-$3.77M
Net Income
$7.78M
Total Assets
$2.99M
Total Liabilities
$4.87M
Stockholders' Equity
$2.14M
Cash & Equivalents
$-18.55
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| 8-K Current report of material events | January 21, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | December 16, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 13, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 7, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 7, 2025 | View on SEC |
Material Events
8-K Legal Issue February 12, 2026
High Impact
- Nasdaq listing secured, successfully resolving the minimum bid price non-compliance.
- Continued market access, visibility, and liquidity for the company's stock are maintained.
Insider Trading
BUY 1 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.